Mark W. Sawicki, Ph.D.
– Global Vice President, Business Development
Mark Sawicki joined CMC Biologics in 2012 as the global vice president, business development. He has nearly 15 years experience with biotechnology, contract research, and manufacturing companies. Prior to CMC Biologics, he was the vice president of business development, Europe at AMRI. Mark has more than a dozen peer reviewed publications as well as dozens of invited speaking engagements at conferences. Mark holds a Bachelors and Doctorate in Biochemistry from the University at Buffalo.
Anders Pedersen – Senior Vice President, Development
Anders Pedersen joined CMC Biologics in 2010 as senior vice president of development. In this position he is responsible for all process development activities in the Copenhagen facility. Anders has more than 25 years of experience in the biopharmaceutical industry. His background experience is in process development and discovery of biopharmaceuticals. Prior to CMC Biologics, he spent 13 years at Novo Nordisk. He was a cofounder of ProFound Pharma, which was later acquired by Maxygen. He also served as vice president of project and portfolio management at Life Cycle Pharma. He has a degree in Chemical Engineering from Danish Technical University in Copenhagen.
Peter Vilby – Senior Vice President, Engineering and Operations Support
A cofounder of the company, Peter Vilby currently serves as senior vice president, engineering and operations support. He has more than 15 years of experience in biopharmaceutical manufacturing. Before CMC Biologics, Peter worked at Novozymes. He has a Master of Science degree in Engineering Science from the Danish Technical University.
Simon Adams, BSc (Hons). – Vice President, Manufacturing
Having joined CMC Biologics in August 2012, Simon is responsible for Manufacturing Operations at the CMC facility in Copenhagen. He brings to the company 15 years of commercial experience in areas such as operational excellence and leadership within contract, generic and large scale Pharmaceutical and Biopharmaceutical organizations. Before joining CMC Biologics, he was Manufacturing Manager at Lonza Biologics in Slough. Prior experience includes Novartis, Actavis, Celltech (Now Recipharm), Royal Naval Reserve and GSK. Simon received a Bachelor of Science degree in Geology from the University of Greenwich.
Roland Hecht, Ph.D. – Vice President, Business Development
Having joined CMC Biologics in 2010, Roland Hecht, Ph.D., is responsible for business development in Europe and Asia. He brings to the company more than 17 years of experience in areas such as management, business development, and sales in the biopharmaceutical and life science research industries. Before joining CMC Biologics, he was senior director of international sales at Rentschler Biotechnologie. Prior experience includes Elchrom Scientific, Excell Biotech, Q-Biogene, and Stratagene (now an Agilent Technologies company). Roland received a Master of Science degree in Biology from the Technical University of Kaiserslatuern and a Ph.D. in Molecular Biology from the University of Homburg. He also completed a three-year Master of Business Administration education concurrent with his Ph.D.
Niels Trolle Ørberg – Vice President, Human Resources
Niels Trolle Ørberg joined CMC Biologics in Copenhagen in 2004 and is responsible for human resources at the Copenhagen facility. Prior to CMC Biologics, he spent 17 years in the medical device industry, holding various managerial positions within manufacturing, product and process development, and quality assurance before specializing in human resources. Niels holds diplomas in Executive Coaching and in Human Resource and Organization Development as well as a higher national diploma in Mechanical Engineering.
Bo Danner Henriksen – Finance Director
Bo Danner Henriksen joined CMC Biologics in Copenhagen in 2012 as Finance Director of the Copenhagen facility. He has nearly 10 years of industry experience in finance from Biotech and Life Sciences companies. Prior to CMC Biologics he held financial management positions at the Exiqon Group and Pharmexa Group. He also had his own consulting business, primarily working in various interim finance management positions at clients. Bo holds a Diploma in Economics Financial and Management Accounting from Copenhagen Business School.